Indian pharma majors deny allegations of price fixing

Category : USA News
Updated On : May 15, 2019 02:31 AM
By Indian Times Daily

Indian pharma majors Dr Reddy’s, Workhardt, Aurobindo and Glenmark, which are among the generic drug makers named in an anti-trust lawsuit in the US, May 14 denied allegations of engaging in conspiracy to fix prices.

The homegrown drugmakers are among the 21 generic pharmaceutical firms and 15 other individual defendants against whom the Attorneys General of 49 US states, the Commonwealth of Puerto Rico and the District of Columbia had filed a complaint with respect to 116 generic drugs in the US District Court for the District of Connecticut.

The companies have been accused of violating antitrust laws by fixing prices and allocating customers.

In separate clarifications to stock exchanges, the companies denied the accusations and stated they would defend themselves in the matter.

Dr Reddy’s said, “We intend to vigorously defend against these allegations and are in the process of filing our response with the District Court of Connecticut.”

Please enter valid email!

Show Please enter password!

Forgot your password?

Please enter name!

Please enter name!

Please enter valid email!

Show At least 6 characters

Lost your password? Please enter your email address. You will receive a link to create a new password.

Please enter valid email!

Back to log-in